HR-Positive and Triple-Negative Metastatic Breast Cancer — An Interview with Dr Laura Huppert on Optimal Integration of ADCs into Treatment
Breast Cancer Update
00:00
What to consider for next therapy after SG in TNBC?
Dr Huppert discusses sequencing options including T‑DXd, intervening chemotherapy, and factors like HER2 IHC and brain metastases.
Play episode from 21:08
Transcript
